NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
+4.55%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.42B
AUM Growth
+$89M
(+3.8%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
10.66%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
53
New
8
Increased
8
Reduced
9
Closed
2
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$182M |
| 2 |
Bolt Biotherapeutics
BOLT
|
$148M |
| 3 |
LAVA Therapeutics
LVTX
|
$50.5M |
| 4 |
Alibaba
BABA
|
$48.7M |
| 5 |
Legend Biotech
LEGN
|
$7.38M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$104M |
| 2 |
Inogen
INGN
|
$41.5M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$14.8M |
| 4 |
INZY
Inozyme Pharma
INZY
|
$11.9M |
| 5 |
Harmony Biosciences
HRMY
|
$9.45M |
Sector Composition
| 1 | Healthcare | 65.06% |
| 2 | Financials | 5.64% |
| 3 | Technology | 5.23% |
| 4 | Communication Services | 3.57% |
| 5 | Consumer Discretionary | 2.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSTX
51
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $377K | 0.02% |
34,819
| – | – |
|
|
CTLT
52
DELISTED
CATALENT, INC.
CTLT
| – | – |
-997,349
| Closed | -$104M |
|
53
Corvus Pharmaceuticals
CRVS
$459M
| – | – |
-847,906
| Closed | -$3.02M |
|